181633-60-3 Usage
Description
Ethyl 2-formyloxazole-4-carboxylate, with the chemical formula C8H9NO4, is a colorless to pale yellow liquid chemical compound. It serves as a versatile intermediate in the synthesis of pharmaceuticals and agrochemicals, as well as other organic compounds. Its potential biological and pharmacological activities have been a subject of study. Due to its potential hazards upon ingestion, inhalation, or skin contact, careful handling and proper storage in a cool, dry place away from heat and direct sunlight are essential.
Uses
Used in Pharmaceutical Industry:
Ethyl 2-formyloxazole-4-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and enhance the properties of existing ones.
Used in Agrochemical Industry:
In the agrochemical sector, Ethyl 2-formyloxazole-4-carboxylate is utilized as an intermediate in the production of agrochemicals, playing a role in the creation of effective and innovative products for agricultural applications.
Used in Organic Synthesis:
Ethyl 2-formyloxazole-4-carboxylate is employed as a building block in the synthesis of other organic compounds, contributing to the advancement of organic chemistry and the development of new materials and substances with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 181633-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,6,3 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 181633-60:
(8*1)+(7*8)+(6*1)+(5*6)+(4*3)+(3*3)+(2*6)+(1*0)=133
133 % 10 = 3
So 181633-60-3 is a valid CAS Registry Number.
181633-60-3Relevant articles and documents
MODULATORS OF THE INTEGRATED STRESS PATHWAY
-
, (2019/05/22)
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
TRICYCLIC PIPERIDINE COMPOUNDS
-
, (2015/06/08)
The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.
2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
-
, (2015/11/17)
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula (I), and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
